| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 431,110 | 396,239 | 391,882 | 369,615 | | Cost of Revenue | 196,483 | 184,752 | 178,201 | 167,107 | | | Gross Profit | 234,627 | 211,487 | 213,681 | 202,508 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 155,242 | 152,893 | 137,917 | 139,968 | | Non Recurring |
-
| 4,900 | 3,977 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 79,385 | 53,694 | 71,787 | 62,540 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,331 | 1,414 | 1,746 | (8) | | Earnings Before Interest And Taxes | 80,716 | 55,108 | 73,533 | 62,532 | | Interest Expense | 422 | 762 | 484 | 1,176 | | Income Before Tax | 80,294 | 54,346 | 73,049 | 61,356 | | Income Tax Expense | 25,723 | 17,275 | 22,163 | 18,491 | | Minority Interest | 156 | (39) |
-
|
-
| | | | Net Income From Continuing Ops | 54,727 | 37,032 | 50,886 | 42,865 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 54,727 | 37,032 | 50,886 | 42,865 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $54,727 | $37,032 | $50,886 | $42,865 |
|
0.26% Nasdaq 
Income Statement
